“Design and Molecular Simulation of a Rituximab-Methimazole Hybrid Compound for Selective Thyroid-Stimulating Hormone Receptor Inhibition in Graves’ Disease”, SciELO Preprints. 22º de julho de 2025. doi: 10.1590/SciELOPreprints.12615.